Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Safe Use of Mirtazapine in Patients Undergoing Peritoneal Dialysis

Patient Monitoring and Care

  • The American College of Physicians recommends regular assessment of residual renal function, as preserving it is crucial for patients undergoing peritoneal dialysis 1
  • Consider the potential impact of mirtazapine on cardiovascular function, as patients on dialysis often have cardiac comorbidities 1
  • Non-pharmacological approaches for treating depression should be considered before initiating pharmacotherapy in patients undergoing peritoneal dialysis 1

Comparison of Peritoneal Dialysis and Hemodialysis

  • The National Kidney Foundation suggests that peritoneal dialysis generally offers better hemodynamic control and fewer acute changes in electrolytes compared to hemodialysis 2
  • Patients with severe cardiovascular disease may be better managed with peritoneal dialysis, as it avoids the rapid changes in solutes and volume that occur during hemodialysis 2
  • Peritoneal dialysis can provide better control of anemia, which is important in patients with coronary artery disease 2

REFERENCES

1

Amitriptyline Use in Patients on Peritoneal Dialysis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025